Integrating advanced microscopy techniques with AI-fueled computational imaging promises to capture brain activity with the depth and speed needed to advance understanding of neurological diseases.Read More
Researchers at Cleveland Clinic’s Center for Pathogen & Human Health Research have identified a novel mechanism for how the body defends itself against viruses using programmed cell destruction.
New research finds that TREM2 deficiency during viral-induced demyelination dysregulates expression of genes regulating phagocytic pathways and lipid metabolism, with distinct effects on recovery.
A new prostate cancer therapy in clinical trials could treat patients resistant to treatment through targeting the disease on a molecular level, based on Cleveland Clinic research.
Application of the novel framework has identified the dyslipidemia medication gemfibrozil as a candidate drug to reduce Alzheimer’s disease risk.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
A broad research effort involving network-medicine methodologies and pharmacoepidemiologic analysis has pinpointed the diabetes medication metformin as a leading antiarrhythmic candidate drug.
A novel soft robotic device designed to fit around the ascending aorta promises to enable high-fidelity simulation of the hemodynamics and biomechanics of aortic stenosis and congenital valve disease.
A combination of pharmacoepidemiologic studies and Mendelian randomization genetic analysis revealed preferential protection in Black but not white individuals. The findings support ongoing studies of telmisartan for Alzheimer’s, particularly in racially diverse cohorts.
A multifront Cleveland Clinic research project aims to use $14 million in NIH funding to identify mechanisms and targets underlying AF that may lead to personalized therapies.
Cleveland Clinic has been selected as a founding partner and the leading healthcare system in a new initiative meant to spur collaboration and innovation in the quantum computing industry. Quantum computers have the potential to advance medical research.
The renowned virologist, who is Cleveland Clinic’s new Global Director of Vaccine Development, discusses his plans and priorities for the research post.